Anika Therapeutics Inc (NASDAQ:ANIK) - Share price - Overview

Stock Report

Anika Therapeutics Inc ANIK

Last Price
$41.41

Day Change
1.91|4.84%

As of 24/05/2018
16:58:55 EDT | USD
Minimum 15 Minutes Delay.

Last Close39.50
Day Range39.75 - 42.51
Mkt Cap610.60Mil
52-Wk Range30.91 - 69.81
Yield %-
ISINUS0352551081
Volume346,824
P/E32.35
P/S5.57
P/CF17.75

Share Price

Financials
201520162017
More ...
Income Statement
Revenue93.00103.38113.42
Operating Income48.1350.6145.73
Net Income30.7632.5531.82
Basic EPS2.062.222.18
Avg. Diluted Shares Outstanding151515
Balance Sheet
Current Assets176.43170.44206.33
Non Current Assets59.3269.8176.29
Total Assets235.75240.25282.62
Current Liabilities17.288.8013.07
Total Liabilities---
Total Equity210.85222.77263.49
Cash Flow
Operating Cash Flow39.0623.8040.81
Capital Expenditure-9.23-14.01-8.98
Free Cash Flow29.849.7931.83

In millions, except "Basic EPS". Currency is USD.

Company Profile

Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

123
Key Stats
More ...
Price/Earning TTM29.48
Price/Book2.21
Price/Sales TTM5.25
Rev Growth (3 year avg)2.41
EPS Growth (3 year avg)-
Operating Margin % TTM40.32
Net Margin % TTM28.05
ROE TTM13.09
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.